Bringing on the generic drugs

Times are tough enough that more people are beginning to switch to generic drugs to save money. Insurers like Indianapolis-based WellPoint are playing a role, too, by pushing policy holders toward generics.

People also are splitting pills and seeing doctors less often to save hard-earned dollars.

The trend could cost pharmaceutical companies like Eli Lilly and Co. $10 billion in revenue in 2009 because prescription drug sales are projected to grow at the slowest rate in at least a half-century.

In the end, how will this affect health? Are people being penny wise and pound foolish? And are you as confident in generic medications as the original drugs?

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our updated comment policy that will govern how comments are moderated.